Drug Side Effects
Search
CUTANEOUS T-CELL LYMPHOMA STAGE III
CUTANEOUS T-CELL LYMPHOMA STAGE III
was reported 23 times
These drug classes are most commonly taken by patients reporting CUTANEOUS T-CELL LYMPHOMA STAGE III:
#
Drug
Count
0
Interleukin-4 Receptor alpha Antagonist [EPC]
14
1
Calcineurin Inhibitor Immunosuppressant [EPC]
6
2
Folate Analog Metabolic Inhibitor [EPC]
6
3
Purine Antimetabolite [EPC]
5
4
Interleukin-23 Antagonist [EPC]
4
5
Anti-IgE [EPC]
3
6
Interleukin-12 Antagonist [EPC]
3
7
Interleukin-17A Antagonist [EPC]
3
8
Retinoid [EPC]
3
9
Tumor Necrosis Factor Blocker [EPC]
3
10
Alkylating Drug [EPC]
2
11
Corticosteroid [EPC]
2
12
Phosphodiesterase 4 Inhibitor [EPC]
2
13
beta3-Adrenergic Agonist [EPC]
2
14
Janus Kinase Inhibitor [EPC]
1
15
Loop Diuretic [EPC]
1
16
Nonsteroidal Anti-inflammatory Drug [EPC]
1
17
Vitamin B12 [EPC]
1
18
Vitamin C [EPC]
1
19
Vitamin D [EPC]
1